Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04155190
Title An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors PellePharm, Inc.
Indications

basal cell carcinoma

Therapies

Patidegib topical gel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.